Ablain, Julien <br/><br/>
p53 as an Effector or Inhibitor of Therapy Response.  [electronic resource] 

 -  Cold Spring Harbor perspectives in medicine  Dec 2015 
 - a026260 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>2157-1422 
<br/><br/><label>Standard No.: </label>10.1101/cshperspect.a026260  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Arsenic Trioxide<br/>Arsenicals--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Molecular Targeted Therapy<br/>Oncogene Proteins, Fusion--genetics<br/>Oxides--administration & dosage<br/>Treatment Outcome<br/>Tretinoin--administration & dosage<br/>Tumor Suppressor Protein p53--metabolism